Carl Zeiss Meditec Stock Today
| CZMWF Stock | USD 61.22 0.00 0.00% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Carl Zeiss is trading at 61.22 as of the 29th of November 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 61.22. Carl Zeiss has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Carl Zeiss Meditec are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 31st of August 2024 and ending today, the 29th of November 2024. Click here to learn more.
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. The company has 89.44 M outstanding shares. More on Carl Zeiss Meditec
Moving together with Carl Pink Sheet
Moving against Carl Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Carl Pink Sheet Highlights
| Business Concentration | Medical Instruments & Supplies, Healthcare (View all Sectors) |
Carl Zeiss Meditec [CZMWF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Large-Cap' category with a current market capitalization of 12.53 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Carl Zeiss's market, we take the total number of its shares issued and multiply it by Carl Zeiss's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Carl Zeiss Meditec classifies itself under Healthcare sector and is part of Medical Instruments & Supplies industry. The entity has 89.44 M outstanding shares.
Carl Zeiss Meditec has accumulated about 8.4 M in cash with 188.2 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.09.
Check Carl Zeiss Probability Of Bankruptcy
Ownership AllocationCarl Zeiss holds a total of 89.44 Million outstanding shares. Carl Zeiss Meditec retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Carl Ownership Details
Carl Zeiss Meditec Risk Profiles
| Mean Deviation | 1.28 | |||
| Standard Deviation | 3.85 | |||
| Variance | 14.85 | |||
| Risk Adjusted Performance | (0.02) |
Carl Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Carl Zeiss without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
| All Next | Launch Module |
Carl Zeiss Corporate Management
| Laurie Ferguson | Head Devices | Profile | |
| Markus Weber | CEO Pres | Profile | |
| Martin Wiechmann | Head Unit | Profile | |
| Andrew Chang | I Meditec | Profile | |
| Euan Thomson | Pres Unit | Profile | |
| Steven MD | Chief Devices | Profile |
Other Information on Investing in Carl Pink Sheet
Carl Zeiss financial ratios help investors to determine whether Carl Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Carl with respect to the benefits of owning Carl Zeiss security.